The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Murphy, M.
Right arrow Articles by Epstein, L. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Murphy, M.
Right arrow Articles by Epstein, L. B.

The Journal of Immunology, Vol 149, Issue 7 2506-2512, Copyright © 1992 by American Association of Immunologists


ARTICLES

Tumor necrosis factor-alpha and IFN-gamma expression in human thymus. Localization and overexpression in Down syndrome (trisomy 21)

M Murphy, DS Friend, L Pike-Nobile and LB Epstein
Department of Pediatrics, University of California, San Francisco 94143.

In vitro studies suggest that TNF-alpha and IFN-gamma regulate thymocyte proliferation, but little evidence exists for the constitutive production of these cytokines in normal human thymus. In paired experiments, we examined frozen sections of postnatal human thymus from four control children and four age-matched children with Down syndrome (DS) (trisomy 21) for TNF-alpha and IFN-gamma mRNA expression using in situ hybridization. We studied thymuses from children with DS because this aneuploid condition is associated with a greatly increased incidence of infection and has abnormal thymic anatomy and patterns of thymocyte maturation. We found cells expressing constitutive levels of TNF-alpha mRNA in the trabeculae, corticomedullary junctions, and medulla of both control and DS thymuses and the number of these cells was an average of 3.9-fold higher in DS thymuses than in age-matched control thymuses. DS thymuses also contained an average of 3 fold higher numbers of cells with mast cell morphology, identified by toluidine blue histologic staining and electron microscopy. In both DS and control thymuses the mast cells colocalized with TNF-alpha mRNA-expressing cells. In addition, TNF- alpha protein- expressing cells, identified by immunohistochemistry, displayed a granular pattern of staining that is characteristic of mast cells. These results suggest that mast cells may be one source of TNF- alpha in human postnatal thymus. Discrete cells expressing IFN-gamma mRNA were distinctly localized to the cortical region of both DS and control thymuses and were 2.4-fold more abundant in DS thymuses than in the controls. Our results demonstrate, for the first time, the constitutive production and location of TNF-alpha and IFN-gamma in postnatal human thymus. The overexpression of both of these cytokines in DS thymuses suggests a dysregulation in cytokine production in DS and may provide an explanation for the abnormal thymic anatomy and thymocyte maturation associated with this syndrome.


This article has been cited by other articles:


Home page
BloodHome page
N. Moulian, F. Truffault, Y. M. Gaudry-Talarmain, A. Serraf, and S. Berrih-Aknin
In vivo and in vitro apoptosis of human thymocytes are associated with nitrotyrosine formation
Blood, June 1, 2001; 97(11): 3521 - 3530.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
B. R. Lackey, S. L. Gray, and D. M. Henricks
Does the Insulin-Like Growth Factor System Interact with Prostaglandins and Proinflammatory Cytokines During Neurodegeneration?
Experimental Biology and Medicine, May 1, 2000; 224(1): 20 - 27.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
J. E. Paz-Miguel, R. Flores, P. Sanchez-Velasco, G. Ocejo-Vinyals, J. Escribano de Diego, J. Lopez de Rego, and F. Leyva-Cobian
Reactive Oxygen Intermediates During Programmed Cell Death Induced in the Thymus of the Ts(1716)65Dn Mouse, a Murine Model for Human Down's Syndrome
J. Immunol., November 15, 1999; 163(10): 5399 - 5410.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. M. Page, E. M. Roberts, J. J. Peschon, and S. M. Hedrick
TNF Receptor-Deficient Mice Reveal Striking Differences Between Several Models of Thymocyte Negative Selection
J. Immunol., January 1, 1998; 160(1): 120 - 133.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. A. Young, D. M. Klinman, D. A. Reynolds, K. J. Grzegorzewski, A. Nii, J. M. Ward, R. T. Winkler-Pickett, J. R. Ortaldo, J. J. Kenny, and K. L. Komschlies
Bone Marrow and Thymus Expression of Interferon-gamma Results in Severe B-Cell Lineage Reduction, T-Cell Lineage Alterations, and Hematopoietic Progenitor Deficiencies
Blood, January 15, 1997; 89(2): 583 - 595.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. H. Chong, J. H. Sung, S. A. Shin, J.-H. Chung, and Y.-H. Suh
Effects of the beta -Amyloid and Carboxyl-terminal Fragment of Alzheimer's Amyloid Precursor Protein on the Production of the Tumor Necrosis Factor-alpha and Matrix Metalloproteinase-9 by Human Monocytic THP-1
J. Biol. Chem., June 22, 2001; 276(26): 23511 - 23517.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1992 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1992 by The American Association of Immunologists, Inc. All rights reserved.